We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0UJF market cap is 1.12B. The company's latest EPS is USD -0.5424 and P/E is -14.66.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 372k | 50.12M | 45.61M | 135.55M | 175.51M |
| Operating Income | -85.3M | -104.29M | -180.74M | -111.47M | -91.69M |
| Net Income | -123.85M | -102.68M | -180.97M | -108.18M | -78.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 326.68M | 463.66M | 543.37M | 470.86M | 548.06M |
| Total Liabilities | 53.17M | 55.91M | 64.28M | 65.43M | 170.11M |
| Total Equity | 273.52M | 407.75M | 479.09M | 405.44M | 377.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.46M | -69.86M | -157.69M | -79.53M | -33.46M |
| Investing | 7.78M | -158.19M | -103.87M | -60.63M | -6.71M |
| Financing | 243.73M | 194.38M | 221.11M | 2.43M | -5.13M |
| Market Cap | 1.12B |
| Price to Earnings Ratio | -14.66 |
| Price to Sales Ratio | 6.51 |
| Price to Cash Ratio | 23.4 |
| Price to Book Ratio | 3.03 |
| Dividend Yield | - |
| Shares Outstanding | 143.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 238 |
| 52 Week Change | 0.00% |
| 52 Week High | 7.80 |
| 52 Week Low | 7.80 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Aurinia Pharmaceuticals Inc |
| Address |
1203-4464 markham street victoria, british columbia V8Z 7X8 |
| Website | https://www.auriniapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
